"Serum phophatidylglycerols as potential gut microbiota derived lipids implicated in fat storage and obesity"

Oral presentation given by ICAN at the Annual ICAN Series, Paris, France, 9th December 2016

Oral presentation given by UNEW at the AASLD Satellite Symposium: ‘NASH: Evaluating Emerging Diagnostic & Treatment Strategies’ Boston, USA, 11th November 2016

Oral presentation given by UMC at the Annual Liver Meeting of the American Association for the Study of Liver Diseases (AASLD), Boston, USA, 11th November 2016

"The combination of Index of NASH score and liver stiffness improves the non-invasive diagnostic accuracy for severe liver fibrosis in patients with Non-Alcoholic Fatty Liver Disease"

Poster presentation given by UNITO at the Annual Liver Meeting of the American Association for the Study of Liver Diseases (AASLD), Boston, USA, 11th - 15th November 2016

"Hepatic macrophage activation is associated with adipose tissue insulin resistance in non-diabetic patients with Non-Alcoholic Fatty Liver Disease"

Poster presentation given by UNITO at the Annual Liver Meeting of the American Association for the Study of Liver Diseases (AASLD), Boston, USA, 11th - 15th November 2016

Oral presentation given by UHEL at the Nordic Masterclass in Hepatology, Copenhagen, Denmark, 1st December 2016

Oral presentation given by UNEW at the National Cancer Research Institute (NCRI) Cancer Conference, Liverpool, UK, 9th November 2016

Oral presentation on risk factors of NAFLD given by CNR at the 22nd Italian meeting of the European Ligand Assay Society, Bologna, Italy, 21st November 2016 

Oral presentation given by UMC at the EASL Monothematic Conference, Riga, Latvia, 12^th – 14^th May 2016

Oral presentation given by CNR at the EASL Monothematic Conference, Riga, Latvia, 12^th – 14^th May 2016